Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4S-PSMA-CAR T Cells for Bladder Cancer
ChiCTR-OIN-17011414Phase 2Recruiting
- Sponsor
- Shenzhen Geno-Immune Medical Institute
- Start
- May 2017
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of 4SCAR-PSMA T cells in bladder cancer, sponsored by Shenzhen Geno-Immune Medical Institute. Primary endpoints: Recurrence, Response rate and 3 more. Started May 2017; status: recruiting.
02
Drugs
4SCAR-PSMA T cells
03
Conditions
bladder cancer
Beyond the preview
Go deeper on ChiCTR-OIN-17011414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIN-17011414.